Exagen to announce third quarter 2022 financial results on november 14, 2022

San diego, oct. 31, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended september 30, 2022, after the market close on monday, november 14, 2022. john aballi, exagen's president and chief executive officer, kamal adawi, chief financial officer, and mark hazeltine, chief operating officer, will host a conference call to review the company's results at 4:30 pm et (1:30 pm pt).
XGN Ratings Summary
XGN Quant Ranking